J H Lin

933 total citations
17 papers, 769 citations indexed

About

J H Lin is a scholar working on Oncology, Molecular Biology and Pharmacology. According to data from OpenAlex, J H Lin has authored 17 papers receiving a total of 769 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 5 papers in Molecular Biology and 5 papers in Pharmacology. Recurrent topics in J H Lin's work include Drug Transport and Resistance Mechanisms (5 papers), Pharmacogenetics and Drug Metabolism (5 papers) and Pharmacological Effects and Toxicity Studies (3 papers). J H Lin is often cited by papers focused on Drug Transport and Resistance Mechanisms (5 papers), Pharmacogenetics and Drug Metabolism (5 papers) and Pharmacological Effects and Toxicity Studies (3 papers). J H Lin collaborates with scholars based in United States and Japan. J H Lin's co-authors include Masato Chiba, D E Duggan, Masayo Yamazaki, Joy A. Nishime, Jerome Hochman, K. C. Yeh, Joseph M. Antonello, Suresh K. Balani, A.N. Chremos and Byron H. Arison and has published in prestigious journals such as Journal of Pharmacology and Experimental Therapeutics, Biochemical Pharmacology and Journal of Pharmaceutical Sciences.

In The Last Decade

J H Lin

17 papers receiving 733 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
J H Lin United States	13	325	209	192	146	140	17	769
F A deLuna United States	15	292 0.9×	218 1.0×	166 0.9×	164 1.1×	85 0.6×	24	844
Elizabeth Formentini United States	10	99 0.3×	176 0.8×	178 0.9×	44 0.3×	82 0.6×	15	555
Sarah Shugarts United States	9	259 0.8×	76 0.4×	134 0.7×	130 0.9×	119 0.8×	13	691
Landry K. Kamdem United States	12	338 1.0×	64 0.3×	326 1.7×	162 1.1×	229 1.6×	21	898
Irma H. Benedek United States	10	85 0.3×	132 0.6×	135 0.7×	40 0.3×	88 0.6×	20	509
William D. Fiske United States	11	90 0.3×	309 1.5×	99 0.5×	54 0.4×	83 0.6×	17	544
Gilbert N. Lam United States	16	96 0.3×	48 0.2×	94 0.5×	156 1.1×	65 0.5×	43	792
Margaret C. Shuhart United States	21	99 0.3×	141 0.7×	291 1.5×	213 1.5×	59 0.4×	32	1.6k
Mirjana Cvetković Serbia	10	903 2.8×	106 0.5×	403 2.1×	215 1.5×	606 4.3×	21	1.4k
Tomoki Imaoka Japan	14	385 1.2×	139 0.7×	133 0.7×	133 0.9×	248 1.8×	20	718

Countries citing papers authored by J H Lin

Since Specialization

Citations

This map shows the geographic impact of J H Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J H Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J H Lin more than expected).

Fields of papers citing papers by J H Lin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J H Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J H Lin. The network helps show where J H Lin may publish in the future.

Co-authorship network of co-authors of J H Lin

This figure shows the co-authorship network connecting the top 25 collaborators of J H Lin. A scholar is included among the top collaborators of J H Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J H Lin. J H Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Hochman, Jerome, Masato Chiba, Joy A. Nishime, Masayo Yamazaki, & J H Lin. (2000). Influence of P-Glycoprotein on the Transport and Metabolism of Indinavir in Caco-2 Cells Expressing Cytochrome P-450 3A4. Journal of Pharmacology and Experimental Therapeutics. 292(1). 310–318. 103 indexed citations

Balani, Suresh K., Xin Xu, Byron H. Arison, et al.. (2000). Metabolites of Caspofungin Acetate, a Potent Antifungal Agent, in Human Plasma and Urine. Drug Metabolism and Disposition. 28(11). 1274–1278. 80 indexed citations

Lin, J H, et al.. (1999). Dose‐dependent plasma clearance of MK‐826, a carbapenem antibiotic, arising from concentration‐dependent plasma protein binding in rats and monkeys. Journal of Pharmaceutical Sciences. 88(2). 277–280. 28 indexed citations

Nishime, Joy A., Regina W. Wang, J H Lin, & Masato Chiba. (1999). Modulation of Rat Cytochrome P-450 by an Investigational HIV Protease Inhibitor. Drug Metabolism and Disposition. 27(9). 972–976. 2 indexed citations

Chiba, Masato, et al.. (1997). Hepatic and intestinal metabolism of indinavir, an HIV protease inhibitor, in rat and human microsomes. Biochemical Pharmacology. 53(8). 1187–1195. 112 indexed citations

Lin, J H, et al.. (1996). IMPROVED ORAL ABSORPTION OF L-365 260, A POORLY SOLUBLE DRUG. Biopharmaceutics & Drug Disposition. 17(1). 1–15. 9 indexed citations

Balani, Suresh K., et al.. (1995). Metabolites of L-735,524, a potent HIV-1 protease inhibitor, in human urine.. Drug Metabolism and Disposition. 23(2). 266–270. 55 indexed citations

Lin, J H, et al.. (1993). Role of calcium in plasma protein binding and renal handling of alendronate in hypo- and hypercalcemic rats.. Journal of Pharmacology and Experimental Therapeutics. 267(2). 670–675. 22 indexed citations

Lin, J H, et al.. (1992). Dose-dependent toxicokinetics of L-689,502, a potent human immunodeficiency virus protease inhibitor, in rats and dogs.. Journal of Pharmacology and Experimental Therapeutics. 263(1). 105–111. 7 indexed citations

10.

Lin, J H. (1991). Pharmacokinetic and Pharmacodynamic Properties of Histamine H2-Receptor Antagonists. Clinical Pharmacokinetics. 20(3). 218–236. 83 indexed citations

11.

Lin, J H, et al.. (1991). Physiological disposition of alendronate, a potent anti-osteolytic bisphosphonate, in laboratory animals.. Drug Metabolism and Disposition. 19(5). 926–932. 132 indexed citations

12.

Lin, J H, et al.. (1988). Effects of age and chronic renal failure on the urinary excretion kinetics of famotidine in man. European Journal of Clinical Pharmacology. 34(1). 41–46. 43 indexed citations

13.

Lin, J H, et al.. (1988). Differential renal handling of angiotensin-converting enzyme inhibitors enalaprilat and lisinopril in rats.. Drug Metabolism and Disposition. 16(3). 392–396. 20 indexed citations

14.

Yeh, K. C., A.N. Chremos, J H Lin, et al.. (1987). Single‐dose pharmacokinetics and bioavailability of famotidine in man. Results of multicenter collaborative studies. Biopharmaceutics & Drug Disposition. 8(6). 549–560. 38 indexed citations

15.

Lin, J H, et al.. (1987). Urinary excretion kinetics of famotidine in rats.. Drug Metabolism and Disposition. 15(2). 212–216. 12 indexed citations

16.

Lin, J H, David M. Cocchetto, K. C. Yeh, & D E Duggan. (1986). Comparative effects of H2-receptor antagonists on drug interaction in rats.. Drug Metabolism and Disposition. 14(6). 649–653. 10 indexed citations

17.

Lin, J H & G Lévy. (1982). Effect of experimental renal failure on sulfate retention and acetaminophen pharmacokinetics in rats.. Journal of Pharmacology and Experimental Therapeutics. 221(1). 80–84. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact